| scholarly article | Q13442814 |
| P2093 | author name string | E Wiercinska | |
| X Zhou | |||
| S Kraus | |||
| M Pham | |||
| H Einsele | |||
| B Weissbrich | |||
| G Stoll | |||
| K Meckel | |||
| L Rasche | |||
| A Mazzoni | |||
| K Nickel | |||
| H Bonig | |||
| C Hopkinson | |||
| W Müllges | |||
| G U Grigoleit | |||
| J Duell | |||
| M J Steinhardt | |||
| K M Kortüm | |||
| F C Krummenast | |||
| M Da-Via | |||
| P2860 | cites work | Progressive multifocal leukoencephalopathy: current treatment options and future perspectives | Q26776236 |
| PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section | Q30613846 | ||
| Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy | Q34505467 | ||
| Development of multifocal leukoencephalopathy in patients undergoing allogeneic stem cell transplantation-can preemptive detection of John Cunningham virus be useful? | Q42205287 | ||
| Unstimulated leukapheresis in patients and donors: comparison of two apheresis systems | Q44681854 | ||
| Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma | Q49908392 | ||
| Automated isolation of primary antigen-specific T cells from donor lymphocyte concentrates: results of a feasibility exercise | Q50446117 | ||
| Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy | Q57281351 | ||
| Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation | Q61798868 | ||
| Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma | Q64240822 | ||
| Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera | Q80732978 | ||
| Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient | Q85157571 | ||
| Cidofovir for treatment of progressive multifocal leukoencephalopathy in a newly diagnosed sarcoidosis patient - a valid therapeutic option? | Q87412136 | ||
| Infectious and immunological sequelae of daratumumab in multiple myeloma | Q89427654 | ||
| P433 | issue | 1 | |
| P921 | main subject | progressive multifocal leukoencephalopathy | Q704930 |
| P304 | page(s) | 177 | |
| P577 | publication date | 2020-04-21 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes | |
| P478 | volume | 18 |
Search more.